If nothing else, the exploration of GAP-43 function and upstream and downstream regulators has stimulated the search for targeted therapeutics directed to facilitate CNS regeneration after axonal injury (see Ribas and Costa, 2017) and possibly, developmental disorders, memory dysfunction and neurodegenerative diseases. Here, GAP43 is linked to neurodegenerative disease.